DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 078347
NDA 078347 describes HALOPERIDOL, which is a drug marketed by Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, SCS, Teva, Teva Pharms, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Fosun Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms, Smith And Nephew, Solopak, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Anda Repository, Cycle Pharms Ltd, Duramed Pharms Barr, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, Vintage, Zydus Pharms Usa, Hospira, Sandoz Inc, Somerset Theraps Llc, and Actavis Mid Atlantic, and is included in one hundred and seven NDAs. It is available from thirty-five suppliers. Additional details are available on the HALOPERIDOL profile page.
The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 078347
| Tradename: | HALOPERIDOL |
| Applicant: | Mylan Labs Ltd |
| Ingredient: | haloperidol lactate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 078347
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 078347 | ANDA | General Injectables and Vaccines, Inc. | 52584-426 | 52584-426-00 | 1 VIAL in 1 BAG (52584-426-00) > 1 mL in 1 VIAL |
| HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 078347 | ANDA | Cardinal Health | 55154-7076 | 55154-7076-5 | 5 VIAL in 1 BAG (55154-7076-5) > 1 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 5MG BASE/ML | ||||
| Approval Date: | Sep 14, 2009 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
